Palomino Laboratories (PALX) Income from Continuing Operations (2023 - 2025)
Palomino Laboratories (PALX) posted Income from Continuing Operations of 1605860.0 for Q3 2025, down 3568.44% sequentially from 43775.0 in Q2 2025, and down 143536.85% YoY from N/an in Q3 2024.
Palomino Laboratories (PALX) Income from Continuing Operations (2023 - 2025) Analysis & Trends
Palomino Laboratories has reported Income from Continuing Operations for 3 years, with the latest figure at 1605860.0 in Q3 2025.
- Quarterly Income from Continuing Operations fell 143536.85% year-over-year to 1605860.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 1811729.0 (down 893.59% YoY) and the FY2024 annual result came in at 145866.0, down 22.73% from the prior year.
- Income from Continuing Operations retreated to 1605860.0 in Q3 2025 per PALX's latest filing, from 43775.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 1118.0 in Q3 2024 and troughed at 1605860.0 in Q3 2025.
- A 3-year average of 226325.89 and a median of 51304.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations jumped 97.39% in 2024, then tumbled 143536.85% in 2025.
- Over 3 years, Income from Continuing Operations stood at 67487.0 in 2023, then slumped by 102.91% to 136938.0 in 2024, then sank by 1072.69% to 1605860.0 in 2025.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 1605860.0, 43775.0, and 25156.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.61 Mn |
| Jun 30, 2025 | -43,775.00 |
| Mar 31, 2025 | -25,156.00 |
| Dec 31, 2024 | -136,938.00 |
| Sep 30, 2024 | -1,118.00 |
| Jun 30, 2024 | -62,432.00 |
| Mar 31, 2024 | -51,304.00 |
| Dec 31, 2023 | -67,487.00 |
| Sep 30, 2023 | -42,863.00 |